Temporal association of stress sensitivity and symptoms in individuals at clinical high risk for psychosis

Psychological Medicine

Volumn 43, Issue 2, 2013, Pages 259-268

  DeVylder, J E ^a   Ben David, S ^b   Schobel, S A ^b   Kimhy, D ^b   Malaspina, D ^c   Corcoran, C M ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Hassles; high risk; life events; prodromal; schizophrenia; stress

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; DISEASE PREDISPOSITION; FEMALE; HUMAN; LIFE EVENT; LONGITUDINAL STUDY; MALE; MENTAL STRESS; PRODROMAL SYMPTOM; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOSIS; RISK FACTOR; SCHIZOPHRENIA; STATISTICAL MODEL; TIME; UNITED STATES;

ADOLESCENT; ADULT; CHILD; CROSS-SECTIONAL STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; LIFE CHANGE EVENTS; LONGITUDINAL STUDIES; MALE; MODELS, STATISTICAL; NEW YORK; PRODROMAL SYMPTOMS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STRESS, PSYCHOLOGICAL; TIME FACTORS; YOUNG ADULT;

MLCS; MLOWN;

EID: 84872100649     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291712001262     Document Type: Article

References (41)

1. Beck AT, Brown G, Epstein N, Steer RA (1988). An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting and Clinical Psychology 56, 893-897. (Pubitemid 19008360)
2. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961). An inventory for measuring depression. Archives of General Psychiatry 4, 561-571.
3. Cannon TD, Huttunen MO, Dahlstrom M, Larmo I, Rasanen P, Juriloo A (2002). Antipsychotic drug treatment in the prodromal phase of schizophrenia. American Journal of Psychiatry 159, 1230-1232. (Pubitemid 34743267)
4. Coddington RD (1972). The significance of life events as etiological factors in the diseases of children. II. A study of a normal population. Journal of Psychosomatic Research 16, 205-213.
5. Cohen S, Kamarck T, Mermelstein R (1983). A global measure of perceived stress. Journal of Health and Social Behavior 24, 386-396.
6. Collip D, Nicolson NA, Lardinois M, Lataster T, van Os J, Myin-Germeys I; G.R.O.U.P. (2011). Daily cortisol, stress reactivity and psychotic experiences in individuals at above average genetic risk for psychosis. Psychological Medicine 41, 2305-2315.
7. Corcoran CM, Kimhy D, Stanford A, Khan S, Walsh J, Thompson J, Schobel S, Harkavy-Friedman J, Goetz R, Colibazzi T, Cressman V, Malaspina D (2008). Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis. Schizophrenia Research 106, 286-293.
8. Corcoran C, Smith C, Mc Laughlin D, Auther AM, Malaspina D, Cornblatt BA (2012). HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia. Schizophrenia Research 135, 170-174.
9. Corcoran C, Walker E, Huot R, Mittal V, Tessner K, Kestler L, Malaspina D (2003). The stress cascade and schizophrenia: etiology and onset. Schizophrenia Bulletin 29, 671-692. (Pubitemid 38181949)
10. Cornblatt BA, Lencz T, Smith CW, Olsen R, Auther AM, Nakayama E, Lesser ML, Tai JY, Shah MR, Foley CA, Kane JM, Correll CU (2007). Can antidepressants be used to treat the schizophrenia prodrome ? Results of a prospective, naturalistic treatment study of adolescents. Journal of Clinical Psychiatry 68, 546-547.
11. Dohrenwend BP (2006). Inventorying stressful life events as risk factors for psychopathology: toward resolution of the problem of intracategory variability. Psychological Bulletin 132, 477-495. (Pubitemid 43848892)
12. Goldstone E, Farhall J, Ong B (2011). Life hassles, experiential avoidance and distressing delusional experiences. Behaviour Research and Therapy 49, 260-266.
13. Grace AA (2012). Dopamine system dysregulation by the hippocampus: implications for the pathophysiology and treatment of schizophrenia. Neuropharmacology 62, 1342-1348.
14. Hawkins KA, Mc Glashan TH, Quinlan D, Miller TJ, Perkins DO, Zipursky RB, Addington J, Woods SW (2004). Factorial structure of the scale of prodromal symptoms. Schizophrenia Research 68, 339-347. (Pubitemid 38526154)
15. Khalili-Mahani N, Dedovic K, Engert V, Pruessner M, Pruessner JC (2010). Hippocampal activation during a cognitive task is associated with subsequent neuroendocrine and cognitive responses to psychological stress. Hippocampus 20, 323-334.
16. Kimhy D, Corcoran C (2008). Use of Palm computer as an adjunct to cognitive-behavioural therapy with an ultra-high-risk patient: a case report. Early Intervention in Psychiatry 2, 234-241.
17. Lee H, Schepp K (2009). The relationship between symptoms and stress in adolescents with schizophrenia. Issues in Mental Health Nursing 30, 736-744.
18. Liang KY, Zeger SL (1986). Longitudinal data analysis using generalized linear models. Biometrika 73, 13-22.
19. Malla RM, Norman RM (1992). Relationship of major life events and daily stressors to symptomatology in schizophrenia. Journal of Nervous and Mental Disease 180, 664-667.
20. Mason O, Startup M, Halpin S, Schall U, Conrad A, Carr V (2004). Risk factors for transition to first episode psychosis among individuals with ' at-risk mental states'. Schizophrenia Research 71, 227-237. (Pubitemid 39330501)
21. Mc Gorry PD, Yung AF, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, Germano D, Bravin J, Mc Donald T, Blair A, Adlard S, Jackson H (2002). Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry 59, 921-928.
22. Miller TJ, Mc Glashan TH, Rosen JL, Cadenhead K, Ventura J, Mc Farlane W, Perkins DO, Pearlson GD, Woods SW (2003). Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophrenia Bulletin 29, 703-715. (Pubitemid 38181951)
23. Moghaddam B (2002). Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders. Biological Psychiatry 51, 775-787. (Pubitemid 34451064)
24. Monroe SM (2008). Modern approaches to conceptualizing and measuring human life stress. Annual Review of Clinical Psychology 4, 33-52. (Pubitemid 351668610)
25. Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, Parker S, Bentall RP (2004). Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. British Journal of Psychiatry 185, 291-297. (Pubitemid 39331330)
26. Norman RM, Malla AK (1993). Stressful life events and schizophrenia. I: A review of the research. British Journal of Psychiatry 162, 161-166. (Pubitemid 23041391)
27. Norman RM, Malla AK (1994). A prospective study of daily stressors and symptomatology in schizophrenic patients. Social Psychiatry and Psychiatric Epidemiology 29, 244-249. (Pubitemid 24350986)
28. Nuechterlein KH, Dawson ME (1984). A heuristic vulnerability/stress model of schizophrenia. Schizophrenia Bulletin 10, 300-312.
29. Pruessner M, Iyer SN, Faridi K, Joober R, Malla AK (2011). Stress and protective factors in individuals at ultra-high risk for psychosis, first episode psychosis and healthy controls. Schizophrenia Research 129, 29-35.
30. Raune D, Bebbington P, Dunn G, Kuipers E (2006). Event attributes and the content of psychotic experiences in first-episode psychosis. Psychological Medicine 36, 221-230. (Pubitemid 43126146)
31. Schlosser DA, Jacobson S, Chen Q, Sugar CA, Niendam TA, Li G, Bearden CE, Cannon TD (2011). Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis. Schizophrenia Bulletin. Published online: 8 August 2011. doi:10.1093/schbul/ sbr098.
32. Schobel SA, Lewandowski NM, Corcoran, CM, Moore H, Brown T, Malaspina D, Small SA (2009). Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders. Archives of General Psychiatry 66, 938-946.
33. Steele GP, Henderson S, Duncan-Jones P (1980). The reliability of reporting adverse experiences. Psychological Medicine 10, 301-306. (Pubitemid 11182308)
34. Tessner KD, Mittal V, Walker EF (2011). Longitudinal study of stressful life events and daily stressors among adolescents at high risk for psychotic disorders. Schizophrenia Bulletin 37, 432-441.
35. Thompson KN, Phillips LJ, Komesaroff P, Yuen HP, Wood SJ, Pantelis C, Velakoulis D, Yung AR, Mc Gorry PD (2007). Stress and HPA-axis functioning in young people at ultra high risk for psychosis. Journal of Psychiatric Research 41, 561-569. (Pubitemid 46330398)
36. Tso IF, Grove TB, Taylor SF (2012). Self-assessment of psychological stress in schizophrenia: preliminary evidence of reliability and validity. Psychiatry Research 195, 39-44.
37. Walker EF, Brennan PA, Esterberg M, Brasfield J, Pearce B, Compton MT (2010). Longitudinal changes in cortisol secretion and conversion to psychosis in at-risk youth. Journal of Abnormal Psychology 119, 401-408.
38. Walker EF, Cornblatt BA, Addington J, Cadenhead KS, Cannon TD, Mc Glashan TH, Perkins PO, Seidman LJ, Tsuang MT, Woods SW, Heinssen R (2009). The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal Sample. Schizophrenia Research 115, 50-57.
39. Walker EF, Diforio D (1997). Schizophrenia: a neural diathesis-stress model. Psychological Review 104, 667-685. (Pubitemid 127499376)
40. Webster MJ, Knable MB, O'Grady J, Orthmann J, Weickert CS (2002). Regional specificity of brain glucocorticoid receptor m RNA alterations in subjects with schizophrenia and mood disorders. Molecular Psychiatry 7, 985-994. (Pubitemid 35333054)
41. Yung AR, Yuen HP, Mc Gorry PD, Phillips LJ, Kelly D, Dell'Olio M, Francey SM, Cosgrave EM, Kilackey E, Stanford C, Godfrey K, Buckby J (2005). Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Australian and New Zealand Journal of Psychiatry 39, 964-971. (Pubitemid 43904432)